Copper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride
C52H64Cl2CuN16O4 — CID 139185524
Data last refreshed: (MolForge compound catalog, from PubChem)
About Copper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride
Copper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride (PubChem CID 139185524) has the molecular formula C52H64Cl2CuN16O4 and a molecular weight of 1111.64 g/mol. Its IUPAC name is copper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride.
Molecular Properties
| Compound Name | Copper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride |
|---|---|
| PubChem CID | 139185524 |
| Molecular Formula | C52H64Cl2CuN16O4 |
| Molecular Weight | 1111.64 g/mol |
| Exact Mass | 1109.40 |
| IUPAC Name | copper;tetrakis(1-[2-(1H-imidazol-5-yl)ethyl]-3-(4-methylphenyl)urea);dichloride |
| SMILES | Cc1ccc(NC(=O)NCCc2cnc[nH]2)cc1.Cc1ccc(NC(=O)NCCc2cnc[nH]2)cc1.Cc1ccc(NC(=O)NCCc2cnc[nH]2)cc1.Cc1ccc(NC(=O)NCCc2cnc[nH]2)cc1.[Cl-].[Cl-].[Cu+2] |
| InChI | InChI=1S/4C13H16N4O.2ClH.Cu/c4*1-10-2-4-11(5-3-10)17-13(18)15-7-6-12-8-14-9-16-12;;;/h4*2-5,8-9H,6-7H2,1H3,(H,14,16)(H2,15,17,18);2*1H;/q;;;;;;+2/p-2 |
| InChIKey | XGHNOZPDWVSSFM-UHFFFAOYSA-L |
| XLogP | 2.33 |
| TPSA | 279.24 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 75 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1111.64 |
| LogP ≤ 5 | 2.33 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139185524 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.